Cell injection aims to prevent deadly liver complication
NCT ID NCT07276568
First seen Jan 11, 2026 · Last updated May 14, 2026 · Updated 22 times
Summary
This early-stage study tests whether injecting special liver-like cells into the belly muscle can help prevent or treat Small-for-Size Syndrome, a serious complication after liver surgery. The trial will enroll 12 patients with liver failure to check safety and early signs of benefit. The goal is to improve survival by supporting liver function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE LIVER FAILURE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Beijing Friendship Hospital, Capital Medical University
Beijing, Province, 100050, China
Conditions
Explore the condition pages connected to this study.